Mark Mueller

Editor

Mark Mueller covers commercial and residential real estate for the Orange County Business Journal. His beat also includes title insurers and mortgage lenders, as well as government stories that relate to real estate. He can be reached at mueller@ocbj.com.

Email: mueller@ocbj.com
Phone: 949-833-8373 Extension: 226

Recent Stories

OCBJ INSIDER

Talent, and Dedication

Chipotle, CFOs, UCI Law, Working Wardrobes

Tease photo

Cryoport HQ Shifts To Nashville Area

HEALTHCARE: CEO moves, Irvine ops remain

Cryoport Inc., the fast-growing provider of cold-chain logistics services for the biopharmaceutical industry, is the latest local company to move its headquarters to the area around Nashville, Tenn.

OCBJ INSIDER

Old School Accolades

Kobe in OC; Red Digital in space

Tease photo

Top Dog

Chihuahua Builds Brewing Base In SoCal, Plans National Expansion

Niche microbrewer Chihuahua Cerveza bids to go national

Tease photo

OCBJ INSIDER

Quarterback Keeper

Steinberg, Mahomes, and Big Games

Tease photo

Fast Funds, Fast-Grower: $85M for Sonendo

MEDTECH: Root canal alternative eyes expansion

From the guys who brought OC Glaukos

Tease photo

Healthpeak Brings Development Push to San Diego

REITS: Plans trophy life science campus

Irvine-based Healthpeak Properties Inc., Orange County’s third-largest public company with a market capitalization topping $18 billion, is adding a new prime life science campus to its already sizeable San Diego-area portfolio.

Tease photo

OCBJ INSIDER: Rinker’s Recollections

The new Star Wars: Galaxy’s Edge ride, Rise of the Resistance, made its debut over the weekend, largely to rave reviews (see our front-page story).

Tease photo

Tarsus Raises $60M to Combat Eyelash Disease

DRUGMAKERS: Bill Link on firm’s board

Irvine-based Tarsus Pharmaceuticals, which is backed by Orange County’s best-known ophthalmology venture capital executive, Bill Link, and several other notable area investors, has raised $60 million to continue testing a drug that aims to be the first of its type to treat a common disease affecting the eye.

Tease photo

OCBJ INSIDER

Power Boards and Brokers

It pays to have David Pyott on your board.

Tease photo

More stories >>